These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 24859746)

  • 1. Dysfunctional Wnt/β-catenin signaling contributes to blood-brain barrier breakdown in Alzheimer's disease.
    Liu L; Wan W; Xia S; Kalionis B; Li Y
    Neurochem Int; 2014 Sep; 75():19-25. PubMed ID: 24859746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wnt signaling in Alzheimer's disease: up or down, that is the question.
    Boonen RA; van Tijn P; Zivkovic D
    Ageing Res Rev; 2009 Apr; 8(2):71-82. PubMed ID: 19101658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Signal transduction during amyloid-beta-peptide neurotoxicity: role in Alzheimer disease.
    Fuentealba RA; Farias G; Scheu J; Bronfman M; Marzolo MP; Inestrosa NC
    Brain Res Brain Res Rev; 2004 Dec; 47(1-3):275-89. PubMed ID: 15572177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two sides of the same coin: Wnt signaling in neurodegeneration and neuro-oncology.
    Caricasole A; Bakker A; Copani A; Nicoletti F; Gaviraghi G; Terstappen GC
    Biosci Rep; 2005; 25(5-6):309-27. PubMed ID: 16307379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of Wnt signaling rescues neurodegeneration and behavioral impairments induced by beta-amyloid fibrils.
    De Ferrari GV; Chacón MA; Barría MI; Garrido JL; Godoy JA; Olivares G; Reyes AE; Alvarez A; Bronfman M; Inestrosa NC
    Mol Psychiatry; 2003 Feb; 8(2):195-208. PubMed ID: 12610652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Wnt/β-catenin signaling in Alzheimer's disease.
    De Ferrari GV; Avila ME; Medina MA; Perez-Palma E; Bustos BI; Alarcon MA
    CNS Neurol Disord Drug Targets; 2014; 13(5):745-54. PubMed ID: 24365184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synaptotoxicity in Alzheimer's disease: the Wnt signaling pathway as a molecular target.
    Inestrosa NC; Varela-Nallar L; Grabowski CP; Colombres M
    IUBMB Life; 2007; 59(4-5):316-21. PubMed ID: 17505971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polyethylenimine-cationized beta-catenin protein transduction activates the Wnt canonical signaling pathway more effectively than cationic lipid-based transduction.
    Kitazoe M; Futami J; Nishikawa M; Yamada H; Maeda Y
    Biotechnol J; 2010 Apr; 5(4):385-92. PubMed ID: 20235145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of Wnt/β-catenin pathway mitigates blood-brain barrier dysfunction in Alzheimer's disease.
    Wang Q; Huang X; Su Y; Yin G; Wang S; Yu B; Li H; Qi J; Chen H; Zeng W; Zhang K; Verkhratsky A; Niu J; Yi C
    Brain; 2022 Dec; 145(12):4474-4488. PubMed ID: 35788280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Restoring Wnt/β-catenin signaling is a promising therapeutic strategy for Alzheimer's disease.
    Jia L; Piña-Crespo J; Li Y
    Mol Brain; 2019 Dec; 12(1):104. PubMed ID: 31801553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence of Wnt/β-catenin alterations in brain and bone of a tauopathy mouse model of Alzheimer's disease.
    Dengler-Crish CM; Ball HC; Lin L; Novak KM; Cooper LN
    Neurobiol Aging; 2018 Jul; 67():148-158. PubMed ID: 29660685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcium/calmodulin-dependent protein kinase type IV is a target gene of the Wnt/beta-catenin signaling pathway.
    Arrázola MS; Varela-Nallar L; Colombres M; Toledo EM; Cruzat F; Pavez L; Assar R; Aravena A; González M; Montecino M; Maass A; Martínez S; Inestrosa NC
    J Cell Physiol; 2009 Dec; 221(3):658-67. PubMed ID: 19711354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting the Wnt/β-catenin signaling pathway in human cancers.
    Yao H; Ashihara E; Maekawa T
    Expert Opin Ther Targets; 2011 Jul; 15(7):873-87. PubMed ID: 21486121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Riluzole: a therapeutic strategy in Alzheimer's disease by targeting the WNT/β-catenin pathway.
    Vallée A; Vallée JN; Guillevin R; Lecarpentier Y
    Aging (Albany NY); 2020 Feb; 12(3):3095-3113. PubMed ID: 32035419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. β-Catenin Is Required for Endothelial Cyp1b1 Regulation Influencing Metabolic Barrier Function.
    Ziegler N; Awwad K; Fisslthaler B; Reis M; Devraj K; Corada M; Minardi SP; Dejana E; Plate KH; Fleming I; Liebner S
    J Neurosci; 2016 Aug; 36(34):8921-35. PubMed ID: 27559173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wnt/β-catenin signal pathway stabilizes APP intracellular domain (AICD) and promotes its transcriptional activity.
    Zhou F; Gong K; van Laar T; Gong Y; Zhang L
    Biochem Biophys Res Commun; 2011 Aug; 412(1):68-73. PubMed ID: 21798242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelial Wnt/β-catenin signaling reduces immune cell infiltration in multiple sclerosis.
    Lengfeld JE; Lutz SE; Smith JR; Diaconu C; Scott C; Kofman SB; Choi C; Walsh CM; Raine CS; Agalliu I; Agalliu D
    Proc Natl Acad Sci U S A; 2017 Feb; 114(7):E1168-E1177. PubMed ID: 28137846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frizzled-1 is involved in the neuroprotective effect of Wnt3a against Abeta oligomers.
    Chacón MA; Varela-Nallar L; Inestrosa NC
    J Cell Physiol; 2008 Oct; 217(1):215-27. PubMed ID: 18521822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Blood-brain barrier and Alzheimer's disease].
    Kuwahara H; Nishida Y; Yokota T
    Brain Nerve; 2013 Feb; 65(2):145-51. PubMed ID: 23399672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apolipoprotein E, amyloid-beta, and blood-brain barrier permeability in Alzheimer disease.
    Donahue JE; Johanson CE
    J Neuropathol Exp Neurol; 2008 Apr; 67(4):261-70. PubMed ID: 18379441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.